A series of acyclonucleosides 6,7-disubstituted 1- (pent-4-enyl)quinoxalin-2-one derivatives and the O-analogs were synthesized by a one-step condensation of the corresponding quinoxaline bases with 5-bromo-1-pentene.The acyclonucleosides prepared were assayed against HIV-1 and HIV-2 in quinoxaline showed inhibition of HIV-1 with EC 50 value of 0.22 ± 0.08 µg/ml and a therapeutic index of 13. This means that it was cytotoxic to MT-4 cells at CC 50 of 2.6 ± 0.1 µg/ml.The use of acyclonucleoside analogs as antiviral chemotherapeutic agents has stimulated extensive research in the synthesis of this class of compounds [1][2][3][4]. The discovery of acyclovir (Zovirax ® ) [5, 6] as a potent antiherpetic drug [7-9] was followed by a great number of chemical analogs of acyclovir such as (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (HBG) (1), 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine (DHPG) 2 [10, 11], 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)adenine (HPMPA) [12] derivatives. Structure−activity relationship studies have shown that the side chains of acyclonucleosides play a crucial role in the interaction of the acyclonucleosides with their antiviral target enzymes [13] (phosphorylation). The orientation of the heterocyclic base about the glycosidic bond in nucleosides is an important conformational parameter, and has been clearly delineated in a variety of enzymatic reactions [14]. These studies prompted us to use the 1,2-dihydroquinoxalone as nucleobase carrying alkyl side chains at N and O atoms, since some quinoxaline derivatives showed a remarkable biological activity [15,16]. The pharmacological applications of quinoxalines include their use as angiotension II receptor antagonists [17], N-methyl-D-aspartate (NMDA) antagonists [18], anti-inflammatory [19], antidepressant-tranquilizing [20, 21], antitumor agents [22,23], as well as the agents against hepatitis B virus (HBV) [24].Recently, Ali and Fathalla [25] have reported the regioselective alkylation of quinoxalines with allyl bromide in the presence of NaH to give a mixture of O-and N-allyl-substituted quinoxalines 3 (27-33%) and __________________________________________________________________________________________